WHO has issued new emergency guidance on the use of licensed Ebola vaccines during Bundibugyo virus disease (BDBV) outbreaks, following an Extraordinary Meeting of the Strategic Advisory Group of Experts on Immunization.
Since evidence remains insufficient to support the programmatic use of the Ervebo vaccine for the prevention of BDBV disease, WHO recommends Ervebo should only be used for BDBV within the context of a research protocol.
Read more:
Thread
Nenhum Voo ainda